[go: up one dir, main page]

MX2010008285A - Forma galenica para la administracion de triptanos por via trans-mucosa bucal. - Google Patents

Forma galenica para la administracion de triptanos por via trans-mucosa bucal.

Info

Publication number
MX2010008285A
MX2010008285A MX2010008285A MX2010008285A MX2010008285A MX 2010008285 A MX2010008285 A MX 2010008285A MX 2010008285 A MX2010008285 A MX 2010008285A MX 2010008285 A MX2010008285 A MX 2010008285A MX 2010008285 A MX2010008285 A MX 2010008285A
Authority
MX
Mexico
Prior art keywords
active ingredient
triptans
transmucosal delivery
oral transmucosal
galenic form
Prior art date
Application number
MX2010008285A
Other languages
English (en)
Inventor
Philippe Perovitch
Marc Maury
Original Assignee
Philippe Perovitch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philippe Perovitch filed Critical Philippe Perovitch
Publication of MX2010008285A publication Critical patent/MX2010008285A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

El objeto de la invención es una forma galénica para la administración por vía trans-mucosa bucal de al menos un principio activo de la familia de los triptanos, que comprenda al menos: dicho principio activo bajo la forma base y bajo la forma de sal, y; una solución hidro-alcohólica que titule al menos 15 grados de alcohol, dicho principio activo que esté presente en estado de disolución estable y completa en la solución hidro-alcohólica, de manera de permitir una absorción rápida de dicho principio activo a través de las mucosas de la cavidad bucal y/o de la orofaringe. La invención concierne también a un procedimiento de obtención de esta formulación galénica así como a su utilización.
MX2010008285A 2008-01-30 2009-01-29 Forma galenica para la administracion de triptanos por via trans-mucosa bucal. MX2010008285A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0850571A FR2926721B1 (fr) 2008-01-30 2008-01-30 Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
PCT/FR2009/050134 WO2009095621A1 (fr) 2008-01-30 2009-01-29 Forme galenique pour l'administration de triptans par voie trans-muqueuse buccale

Publications (1)

Publication Number Publication Date
MX2010008285A true MX2010008285A (es) 2010-10-04

Family

ID=39766922

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008285A MX2010008285A (es) 2008-01-30 2009-01-29 Forma galenica para la administracion de triptanos por via trans-mucosa bucal.

Country Status (15)

Country Link
US (1) US9801815B2 (es)
EP (1) EP2252263B1 (es)
JP (1) JP5435659B2 (es)
CN (1) CN101983052B (es)
AT (1) ATE516015T1 (es)
BR (1) BRPI0907203A2 (es)
CA (1) CA2713163C (es)
DK (1) DK2252263T3 (es)
ES (1) ES2369747T3 (es)
FR (1) FR2926721B1 (es)
MX (1) MX2010008285A (es)
PL (1) PL2252263T3 (es)
PT (1) PT2252263E (es)
RU (1) RU2492852C2 (es)
WO (1) WO2009095621A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3031668A1 (fr) 2015-01-20 2016-07-22 Philippe Perovitch Dispositif d'administration d'un principe actif par voie per-muqueuse buccale.
FR3053244A1 (fr) 2016-07-01 2018-01-05 Philippe Perovitch Dispositif d'administration d'au moins un principe actif par voie per-muqueuse buccale.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
IT1291895B1 (it) * 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
CN1145486C (zh) * 1997-07-03 2004-04-14 美国辉瑞有限公司 含eletriptan半硫酸盐和咖啡因的药用组合物
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
US20070166336A1 (en) * 2005-12-13 2007-07-19 David Delmarre Stable and palatable oral liquid sumatriptan compositions
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs

Also Published As

Publication number Publication date
RU2010136277A (ru) 2012-03-10
US20100298401A1 (en) 2010-11-25
FR2926721A1 (fr) 2009-07-31
FR2926721B1 (fr) 2011-07-22
EP2252263A1 (fr) 2010-11-24
BRPI0907203A2 (pt) 2015-07-14
CN101983052A (zh) 2011-03-02
PT2252263E (pt) 2011-10-19
CA2713163A1 (fr) 2009-08-06
ATE516015T1 (de) 2011-07-15
WO2009095621A1 (fr) 2009-08-06
EP2252263B1 (fr) 2011-07-13
ES2369747T3 (es) 2011-12-05
CN101983052B (zh) 2013-03-20
JP5435659B2 (ja) 2014-03-05
DK2252263T3 (da) 2011-10-31
US9801815B2 (en) 2017-10-31
JP2011510962A (ja) 2011-04-07
RU2492852C2 (ru) 2013-09-20
CA2713163C (fr) 2016-11-08
PL2252263T3 (pl) 2011-12-30

Similar Documents

Publication Publication Date Title
MX2009003030A (es) Forma galenita para la administracion por via transmucosa de principios activos.
PL1998762T3 (pl) Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
WO2007067582A3 (en) Process for manufacturing chewable dosage forms for drug delivery and products thereof
WO2008027854A3 (en) Pharmaceutical compositions comprising hgh for oral delivery
EP3895699A3 (en) Pharmaceutical compositions comprising iron oxy-hydroxide
IL199187A (en) Indole history, pharmaceuticals including them and their use in the manufacture of medicines
IL190838A0 (en) Intranasal administration of rapid acting insulin
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
WO2005039499A3 (en) Rapidly disintegrating film
EP2219626A4 (en) METHOD FOR MANUFACTURING DOSAGE FORMS FOR THE DELIVERY OF MEDICAMENTS AND PRODUCTS CONTAINING SAME
IL189375A (en) Derivatives 1-Heterocyclicsulfonyl-3-Aminomethyl-5- (hetero-) aryl-1-h- Pyrol
IL231576A (en) Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
MX339470B (es) Formulacion que contiene nicotina.
WO2008087323A3 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
MX2011006797A (es) Una formulación para administración oral transmucósica de fármacos reductores de lípidos.
MX2010008285A (es) Forma galenica para la administracion de triptanos por via trans-mucosa bucal.
GB2443793B (en) Product, method of manufacture and use
TR200806300A2 (tr) Çözünürlük artırıcı farmasötlk formulasyon
NO20055601D0 (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
ATE471712T1 (de) Pharmazeutische zusammensetzung mit tetrahydrolipstatin
TR200806302A2 (tr) Çözünürlük ve stabilite artırıcı farmasötik formülasyon.

Legal Events

Date Code Title Description
FG Grant or registration